{"transactions":[{"id":910742,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-02-11T21:03:58.000Z","date":"2026-02-09","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 10, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The stock option award vested in four equal annual installments, commencing one year after the date of grant."}],"balance_after":905,"derivative":{"exercise_price":492,"expiration_date":"2030-12-09","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0002009236-26-000001","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/872589/000200923626000001/edgardoc.xml","form_type":"4"}},{"id":910741,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2026-02-11T21:03:58.000Z","date":"2026-02-09","kind":"sale","planned":true,"acquired":false,"shares":53,"price":785.72,"value":41643.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents volume-weighted average price of sales of 53 shares of Company stock on February 9, 2026 at prices ranging from $785.72 to $785.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price."}],"balance_after":4272,"source":{"system":"sec-edgar","filing":"0002009236-26-000001","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000200923626000001/edgardoc.xml","form_type":"4"}},{"id":910740,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2026-02-11T21:03:58.000Z","date":"2026-02-09","kind":"sale","planned":true,"acquired":false,"shares":1,"price":784.66,"value":784.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 10, 2025."}],"balance_after":4325,"source":{"system":"sec-edgar","filing":"0002009236-26-000001","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000200923626000001/edgardoc.xml","form_type":"4"}},{"id":910739,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2026-02-11T21:03:58.000Z","date":"2026-02-09","kind":"sale","planned":true,"acquired":false,"shares":144,"price":783.23,"value":112785.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents volume-weighted average price of sales of 144 shares of Company stock on February 9, 2026 at prices ranging from $783.17 to $783.29. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price."}],"balance_after":4326,"source":{"system":"sec-edgar","filing":"0002009236-26-000001","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000200923626000001/edgardoc.xml","form_type":"4"}},{"id":910738,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2026-02-11T21:03:58.000Z","date":"2026-02-09","kind":"sale","planned":true,"acquired":false,"shares":37,"price":782.67,"value":28958.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents volume-weighted average price of sales of 37 shares of Company stock on February 9, 2026 at prices ranging from $782.22 to $782.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price."}],"balance_after":4470,"source":{"system":"sec-edgar","filing":"0002009236-26-000001","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000200923626000001/edgardoc.xml","form_type":"4"}},{"id":910737,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2026-02-11T21:03:58.000Z","date":"2026-02-09","kind":"sale","planned":true,"acquired":false,"shares":26,"price":781.37,"value":20315.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents volume-weighted average price of sales of 26 shares of Company stock on February 9, 2026 at prices ranging from $781.18 to $781.53. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price."}],"balance_after":4507,"source":{"system":"sec-edgar","filing":"0002009236-26-000001","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000200923626000001/edgardoc.xml","form_type":"4"}},{"id":910736,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2026-02-11T21:03:58.000Z","date":"2026-02-09","kind":"sale","planned":true,"acquired":false,"shares":75,"price":780.06,"value":58504.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 75 shares of Company stock on February 9, 2026 at prices ranging from $780.03 to $780.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price."}],"balance_after":4533,"source":{"system":"sec-edgar","filing":"0002009236-26-000001","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000200923626000001/edgardoc.xml","form_type":"4"}},{"id":910735,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2026-02-11T21:03:58.000Z","date":"2026-02-09","kind":"sale","planned":true,"acquired":false,"shares":205,"price":779.56,"value":159809.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 205 shares of Company stock on February 9, 2026 at prices ranging from $779.19 to $779.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price."}],"balance_after":4608,"source":{"system":"sec-edgar","filing":"0002009236-26-000001","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000200923626000001/edgardoc.xml","form_type":"4"}},{"id":910734,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2026-02-11T21:03:58.000Z","date":"2026-02-09","kind":"sale","planned":true,"acquired":false,"shares":563,"price":778.35,"value":438211.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 563 shares of Company stock on February 9, 2026 at prices ranging from $778.00 to $778.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price."}],"balance_after":4813,"source":{"system":"sec-edgar","filing":"0002009236-26-000001","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000200923626000001/edgardoc.xml","form_type":"4"}},{"id":910733,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2026-02-11T21:03:58.000Z","date":"2026-02-09","kind":"sale","planned":true,"acquired":false,"shares":391,"price":777.51,"value":304006.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 391 shares of Company stock on February 9, 2026 at prices ranging from $777.33 to $777.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price."}],"balance_after":5376,"source":{"system":"sec-edgar","filing":"0002009236-26-000001","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000200923626000001/edgardoc.xml","form_type":"4"}},{"id":910732,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2026-02-11T21:03:58.000Z","date":"2026-02-09","kind":"sale","planned":true,"acquired":false,"shares":521,"price":776.43,"value":404520.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 521 shares of Company stock on February 9, 2026 at prices ranging from $776.05 to $776.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price."}],"balance_after":5767,"source":{"system":"sec-edgar","filing":"0002009236-26-000001","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000200923626000001/edgardoc.xml","form_type":"4"}},{"id":910731,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2026-02-11T21:03:58.000Z","date":"2026-02-09","kind":"sale","planned":true,"acquired":false,"shares":20,"price":775.95,"value":15519.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 10, 2025."}],"balance_after":6288,"source":{"system":"sec-edgar","filing":"0002009236-26-000001","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000200923626000001/edgardoc.xml","form_type":"4"}},{"id":910730,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2026-02-11T21:03:58.000Z","date":"2026-02-09","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":492,"value":492000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 10, 2025."}],"balance_after":6308,"source":{"system":"sec-edgar","filing":"0002009236-26-000001","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000200923626000001/edgardoc.xml","form_type":"4"}},{"id":976916,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-12-09T22:38:25.000Z","date":"2025-12-05","kind":"grant","planned":false,"acquired":true,"shares":2261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":2261,"derivative":{"exercise_price":726.71,"expiration_date":"2035-12-05","underlying":"Common Stock","underlying_shares":2261},"source":{"system":"sec-edgar","filing":"0002009236-25-000008","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000200923625000008/edgardoc.xml","form_type":"4"}},{"id":976915,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Common Stock","published_at":"2025-12-09T22:38:25.000Z","date":"2025-12-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":989,"price":712.94,"value":705097.66,"ownership":{"direct":true},"balance_after":5308,"source":{"system":"sec-edgar","filing":"0002009236-25-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000200923625000008/edgardoc.xml","form_type":"4"}},{"id":976914,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Common Stock","published_at":"2025-12-09T22:38:25.000Z","date":"2025-12-05","kind":"grant","planned":false,"acquired":true,"shares":2064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 5, 2027 and 50% on December 5, 2029."}],"balance_after":6297,"source":{"system":"sec-edgar","filing":"0002009236-25-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000200923625000008/edgardoc.xml","form_type":"4"}},{"id":1004313,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Common Stock","published_at":"2025-11-10T21:37:37.000Z","date":"2025-11-07","kind":"sale","planned":false,"acquired":false,"shares":431,"price":651.43,"value":280766.33,"ownership":{"direct":true},"balance_after":4233,"source":{"system":"sec-edgar","filing":"0002009236-25-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000200923625000006/edgardoc.xml","form_type":"4"}},{"id":1327435,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Common Stock","published_at":"2024-12-18T21:02:48.000Z","date":"2024-12-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":298,"price":730.81,"value":217781.38,"ownership":{"direct":true},"balance_after":4664,"source":{"system":"sec-edgar","filing":"0001968202-24-000140","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000140/edgardoc.xml","form_type":"4"}},{"id":1338123,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-12-10T21:03:48.000Z","date":"2024-12-06","kind":"grant","planned":false,"acquired":true,"shares":3236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":3236,"derivative":{"exercise_price":771.64,"expiration_date":"2034-12-06","underlying":"Common Stock","underlying_shares":3236},"source":{"system":"sec-edgar","filing":"0001883850-24-000051","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000051/edgardoc.xml","form_type":"4"}},{"id":1338122,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Common Stock","published_at":"2024-12-10T21:03:48.000Z","date":"2024-04-29","kind":"gift","planned":false,"acquired":true,"shares":90,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":179,"source":{"system":"sec-edgar","filing":"0001883850-24-000051","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000051/edgardoc.xml","form_type":"4"}},{"id":1338121,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Common Stock","published_at":"2024-12-10T21:03:48.000Z","date":"2024-04-04","kind":"gift","planned":false,"acquired":true,"shares":89,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":89,"source":{"system":"sec-edgar","filing":"0001883850-24-000051","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000051/edgardoc.xml","form_type":"4"}},{"id":1338120,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Common Stock","published_at":"2024-12-10T21:03:48.000Z","date":"2024-12-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":149,"price":787,"value":117263.0,"ownership":{"direct":true},"balance_after":4962,"source":{"system":"sec-edgar","filing":"0001883850-24-000051","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000051/edgardoc.xml","form_type":"4"}},{"id":1338119,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Common Stock","published_at":"2024-12-10T21:03:48.000Z","date":"2024-12-06","kind":"grant","planned":false,"acquired":true,"shares":907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 6, 2026 and 50% on December 6, 2028."}],"balance_after":5111,"source":{"system":"sec-edgar","filing":"0001883850-24-000051","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000051/edgardoc.xml","form_type":"4"}},{"id":1439173,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-08-07T20:40:11.000Z","date":"2024-08-07","kind":"exercise","planned":false,"acquired":false,"shares":487,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":372.46,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":487},"source":{"system":"sec-edgar","filing":"0001883850-24-000043","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000043/edgardoc.xml","form_type":"4"}},{"id":1439172,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Common Stock","published_at":"2024-08-07T20:40:11.000Z","date":"2024-08-07","kind":"sale","planned":false,"acquired":false,"shares":487,"price":1070,"value":521090.0,"ownership":{"direct":true},"balance_after":4204,"source":{"system":"sec-edgar","filing":"0001883850-24-000043","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000043/edgardoc.xml","form_type":"4"}},{"id":1439171,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":66935,"kind":"person","name":"Pitofsky Jason","position":1,"cik":"0002009236","reported_name":"Pitofsky Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Common Stock","published_at":"2024-08-07T20:40:11.000Z","date":"2024-08-07","kind":"exercise","planned":false,"acquired":true,"shares":487,"price":372.46,"value":181388.02,"ownership":{"direct":true},"balance_after":4691,"source":{"system":"sec-edgar","filing":"0001883850-24-000043","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000043/edgardoc.xml","form_type":"4"}}]}